highperformr logo

Nicole Junkermann

Member Board of Trustees, The Royal Marsden Cancer Charity
,United Kingdom
Find Nicole Junkermann's Email
Find Nicole Junkermann’s Phone

Nicole Junkermann's Overview

Total Experience103 years
CompanyThe Royal Marsden Cancer Charity
CountryUnited Kingdom

Nicole Junkermann is a German-born, London-based international entrepreneur and investor, and the founder of NJF Holdings, an international investment company. Her investment focus is primarily on deep tech, healthcare, and biotech, seeking out companies poised for significant global impact. With a keen eye for disruptive technologies, Junkermann has backed a diverse portfolio of early-stage and growth-stage companies across Europe, the US, and Israel. She is recognized for her ability to identify emerging trends and support founders in scaling their businesses. Prior to focusing solely on her investment activities through NJF Holdings, she was involved in various ventures, including co-founding an online sports gaming platform and investing in media and technology.

Professional Summary

Nicole Junkermann's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

The Royal Marsden Cancer Charity - Member Board of Trustees (2024 to Present)
Royal Academy of Arts - Trustee (2023 to Present)
NJF Holdings - Founder (2012 to Present)
Owkin - Investor and Director (2017 to Present)
Shanghai Really Sports Equipment Co. Ltd. - Investor and Director (2005 to Present)
Trilantic Europe - Advisor (2012 to Present)
Tate Americas Foundation - Committee Member – Latin American Acquisitions (2005 to Present)
JJ Collection - Founder (2014 to Present)
Infront Holding & Infront Sports & Media AG Switzerland - Investor and Vice Chairman (2002 to 2011)
United in Sports (Fund) - Founder (2007 to 2011)

Notable Achievements

Founder of NJF Holdings

Established NJF Holdings, an international investment company focusing on venture capital, private equity, and real estate, with a significant emphasis on disruptive technologies in sectors like deep tech, biotech, and healthcare.

Pioneer in Deep Tech and Health Tech Investment

Recognized as an early and prominent investor in deep technology and healthcare innovation, backing companies aiming to solve complex global challenges in areas like artificial intelligence, biotechnology, and digital health.

Global Investment Portfolio

Successfully built and manages a diverse portfolio of investments in innovative companies across key technology hubs including Europe, the United States, and Israel, fostering international collaboration and growth.

Advocate for Technology and Innovation

Actively contributes to discussions on the future of technology and innovation through speaking engagements, publications, and thought leadership, promoting the positive impact of technological advancements on society and business.

Early Supporter of Disruptive Ventures

Has a track record of identifying and supporting disruptive companies from their early stages, helping them navigate growth and achieve market leadership.

Educational Background

Executive Certificate in Public Policy

Harvard Kennedy School - Year 2021

Agribusiness

Harvard Business School - Year 2021

Programme for Management Development

Harvard Business School Executive Education - Year 2002

BS in Business Administration, BS in Business Administration

International University of Monaco - Year 1995

Buying Intent Signals for Nicole Junkermann

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

The Royal Marsden Cancer Charity
Total employees121
HeadquartersLondon
Founded1999

The Royal Marsden Cancer Charity raises money solely to support The Royal Marsden, a world-leading cancer centre. They ensure their nurses, doctors, and research teams can provide the very best care and develop life-saving treatments, which are used across the UK and around the world. From funding state-of-the-art equipment and ground-breaking research to creating the best patient environments, they aim to improve the lives of people affected by cancer by investing in a future beyond cancer.

The Royal Marsden Cancer Charity Funding Information
Not applicable - Total Funding Raised
Not applicable - Most recent funding amount
Not applicable - Number of funding rounds
Not applicable - Latest funding round
Lead Investors:
Primarily funded through public donations, legacies, community fundraising, corporate partnerships, and grants from trusts and foundations. As a charity, it does not have 'investors' in the commercial sense.

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.